Dr. Kevin Bielamowicz, MD
Claim this profileArkansas Children's Hospital
Area of expertise
Neuroblastoma
Kevin Bielamowicz, MD has run 4 trials for Neuroblastoma. Some of their research focus areas include:
Acute Myeloid Leukemia
Kevin Bielamowicz, MD has run 2 trials for Acute Myeloid Leukemia. Some of their research focus areas include:
Affiliated Hospitals
Arkansas Children's Hospital
Arkansas Children's Research Institute
Clinical Trials Kevin Bielamowicz, MD is currently running
DFMO
for Medulloblastoma
Difluoromethylornithine (DFMO) will be used in an open label, multicenter, study as Maintenance Therapy for Molecular High Risk/Very High Risk and Relapsed/Refractory Medulloblastoma.
Recruiting
1 award
Phase 2
Talazoparib + Chemotherapy
for Acute Myeloid Leukemia
This trial is testing the safety of using talazoparib with standard chemotherapy in cancer patients. Talazoparib works by stopping cancer cells from repairing themselves, which could make chemotherapy more effective. The study aims to find the safest dose combination and see if this approach helps patients. Talazoparib is FDA approved for certain types of breast cancer that have spread and were previously treated with chemotherapy.
Recruiting
1 award
Phase 1
19 criteria
More about Kevin Bielamowicz, MD
Clinical Trial Related
7 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 7 Active Clinical Trials
Treatments Kevin Bielamowicz, MD has experience with
- Ceritinib
- Topotecan
- Talazoparib
- Gemcitabine
- Ponatinib
- Induction
Breakdown of trials Kevin Bielamowicz, MD has run
Neuroblastoma
Acute Myeloid Leukemia
Brain Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kevin Bielamowicz, MD specialize in?
Kevin Bielamowicz, MD focuses on Neuroblastoma and Acute Myeloid Leukemia. In particular, much of their work with Neuroblastoma has involved MYC positive patients, or patients who are undergoing treatment.
Is Kevin Bielamowicz, MD currently recruiting for clinical trials?
Yes, Kevin Bielamowicz, MD is currently recruiting for 7 clinical trials in Little Rock Arkansas. If you're interested in participating, you should apply.
Are there any treatments that Kevin Bielamowicz, MD has studied deeply?
Yes, Kevin Bielamowicz, MD has studied treatments such as Ceritinib, Topotecan, Talazoparib.
What is the best way to schedule an appointment with Kevin Bielamowicz, MD?
Apply for one of the trials that Kevin Bielamowicz, MD is conducting.
What is the office address of Kevin Bielamowicz, MD?
The office of Kevin Bielamowicz, MD is located at: Arkansas Children's Hospital, Little Rock, Arkansas 72202 United States. This is the address for their practice at the Arkansas Children's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.